Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Gavocabtagene autoleucel |
Trade Name | |
Synonyms | Gavo-cel|TC 210|TC-210|TC210 |
Drug Descriptions |
Gavocabtagene autoleucel are T cells engineered to express an anti-mesothelin (MSLN) antibody linked to a CD3 epsilon subunit, with potential activity against MSLN-expressing tumors (Cancer Res 2021;81(13_Suppl):Abstract nr CT105). |
DrugClasses | MSLN Antibody 12 |
CAS Registry Number | NA |
NCIT ID | C160780 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Gavocabtagene autoleucel | Gavocabtagene autoleucel | 0 | 1 |
Gavocabtagene autoleucel + Ipilimumab + Nivolumab | Gavocabtagene autoleucel Ipilimumab Nivolumab | 0 | 1 |
Gavocabtagene autoleucel + Nivolumab | Gavocabtagene autoleucel Nivolumab | 0 | 1 |